$2.09
1.46%
Nasdaq, Aug 22, 10:00 pm CET
ISIN
US03837C1062
Symbol
APYX

Apyx Medical Corporation Stock price

$2.09
-0.16 7.11% 1M
+0.66 46.15% 6M
+0.51 32.28% YTD
+0.79 60.77% 1Y
-4.45 68.04% 3Y
-2.71 56.46% 5Y
-0.21 9.13% 10Y
-0.10 4.57% 20Y
Nasdaq, Closing price Fri, Aug 22 2025
+0.03 1.46%

Key metrics

Basic
Market capitalization
$79.0m
Enterprise Value
$84.2m
Net debt
$5.1m
Cash
$29.3m
Shares outstanding
37.8m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
1.7 | 1.6
EV/Sales
1.8 | 1.7
EV/FCF
negative
P/B
10.9
Financial Health
Equity Ratio
21.9%
Return on Equity
-165.1%
ROCE
-25.9%
ROIC
-50.9%
Debt/Equity
4.7
Financials (TTM | estimate)
Revenue
$46.5m | $49.2m
EBITDA
$-11.8m | $-6.9m
EBIT
$-12.3m | $-10.6m
Net Income
$-17.3m | $-13.9m
Free Cash Flow
$-10.0m
Growth (TTM | estimate)
Revenue
-5.2% | 2.3%
EBITDA
46.4% | 62.2%
EBIT
45.5% | 43.5%
Net Income
39.2% | 40.8%
Free Cash Flow
-2.6%
Margin (TTM | estimate)
Gross
61.6%
EBITDA
-25.3% | -14.0%
EBIT
-26.5%
Net
-37.1% | -28.2%
Free Cash Flow
-21.6%
More
EPS
$-0.4
FCF per Share
$-0.3
Short interest
0.9%
Employees
220
Rev per Employee
$220.0k
Show more

Is Apyx Medical Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,015 stocks worldwide.

Apyx Medical Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a Apyx Medical Corporation forecast:

6x Buy
67%
3x Hold
33%

Analyst Opinions

9 Analysts have issued a Apyx Medical Corporation forecast:

Buy
67%
Hold
33%

Financial data from Apyx Medical Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
47 47
5% 5%
100%
- Direct Costs 18 18
4% 4%
38%
29 29
6% 6%
62%
- Selling and Administrative Expenses 37 37
22% 22%
80%
- Research and Development Expense 3.89 3.89
27% 27%
8%
-12 -12
46% 46%
-25%
- Depreciation and Amortization 0.56 0.56
15% 15%
1%
EBIT (Operating Income) EBIT -12 -12
45% 45%
-26%
Net Profit -17 -17
39% 39%
-37%

In millions USD.

Don't miss a Thing! We will send you all news about Apyx Medical Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Apyx Medical Corporation Stock News

Neutral
Seeking Alpha
16 days ago
Apyx Medical Corporation (NASDAQ:APYX ) Q2 2025 Earnings Conference Call August 7, 2025 4:30 PM ET Company Participants Charles D. Goodwin - President, CEO & Director Matthew C.
Neutral
GlobeNewsWire
17 days ago
CLEARWATER, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency platform technology marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today reported financial results for its quarter ended June 30, 2025.
Neutral
GlobeNewsWire
25 days ago
CLEARWATER, Fla., July 30, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion® and the AYON Body Contouring System™, today announced that management will participate in the Canaccord Genuity 45th Annual Growth Conference on Tuesday, August 12,...
More Apyx Medical Corporation News

Company Profile

Apyx Medical Corp. operates as an energy-based medical technology company. The firm engages in developing, manufacturing, and marketing a range of electrosurgical products and technologies, as well as related medical products used the offices of doctors, surgery centers, and hospitals worldwide. It operates through the following segments: Advanced Energy and Original Equipment Manufacture (OME). The company was founded by Andrew Makrides in 1978 and is headquartered in Clearwater, FL.

Head office United States
CEO Charles Goodwin
Employees 220
Founded 1978
Website apyxmedical.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today